Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast
Key Highlights
- ➤Co-Diagnostics (CODX) will release Q3 2026 results November 12 after market close
- ➤Management will host an earnings webcast and conference call at 4:30 p.m. ET
- ➤Co-Dx PCR at-home and point-of-care platform remains subject to regulatory review and unavailable for sale
Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast PR Newswire
SALT LAKE CITY, Oct. 29, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release its third quarter 2026 financial results on Thursday, November 12, 2026, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer and Daniel Bohrer, Executive Vice President of Finance and Accounting.
Get started
Create a free account to read the full story.